03.06.2013 17:51 Uhr, Quelle: Wallstreet online

DGAP-News: WILEX AG: Phase III ARISER data for the adjuvant treatment of clear cell renal cancer with RENCAREX(R) including retrospective subgroup analysis presented at ASCO

DGAP-News: WILEX AG / Key word(s): Research Update WILEX AG: Phase III ARISER data for the adjuvant treatment of clear cell renal cancer with RENCAREX(R) including retrospective subgroup analysis presented at ASCO 03.06.2013 / …

Weiterlesen bei Wallstreet online

Digg del.icio.us Facebook email MySpace Technorati Twitter

JustMac.info © Thomas Lohner - Impressum - Datenschutz